Love Pharma Sells Microdoz, Increases Focus on Biotechnology

VANCOUVER, BC / ACCESSWIRE / December 14, 2022 / LOVE Pharma Co. ("LOVE" and or "The Company") (CSE:LUV)(FSE:G1Q0), the Company today announced a strategic move to sell its wholly owned subsidiary Microdoz Therapy Inc. ("Microdoz"), as part of its …